ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Isolation and identification of angiogenesis-promoting components in Huanglian Jiedu decoction using live cell bio-specific extraction

Liao, Fengyun; He, Dongmei; Liu, Cuiting; Vong, Chi Teng; Zhong, Zhangfeng*; Wang, Yitao*南方医科大学; 5
Journal of Ethnopharmacology2023-3-1DOI: 10.1016/j.jep.2022.115961
3被引19阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Huanglian Jiedu Decoction (HLJDD) is a traditional heat-dissipating and detoxicating prescription used in Chinese medicine and has been extensively applied in the clinical treatment of ischemic stroke. Preliminary research confirmed that HLJDD exerts a neuroprotective effect on brain tissue injury caused by cerebral ischemia by promoting angiogenesis. However, the components of HLJDD responsible for its medicinal activity in ischemic injury remain unclear. Aim of the study: The aim of this study was to identify the active components of HLJDD that could promote angiogenesis and investigate its underlying mechanism, as well as Hypoxia-inducible factor-1 alpha (HIF-1 alpha)/ Vascular endothelial growth factor (VEGF) signalings in human umbilical vein endothelial cells (HUVECs). Materials and methods: The specific binding components of HLJDD with HUVECs were isolated and identified through a combination of live cell biospecific extraction, solid-phase extraction, and ultra performance liquid chromatography (UPLC)-Orbitrap Fusion Tribrid mass spectrometry (MS). Their pharmacological activity against oxygen-glucose deprivation-reperfusion (OGD/R) injury and in vitro pro-angiogenesis was validated using Cell Counting Kit-8 (CCK-8) and tube formation analysis, respectively. Finally, we explored the effect of active ingredients on the expression levels of HIF-1 alpha and VEGF using enzyme-linked immunosorbent assay. Molecular docking was used to predict the potential binding of six active components to phosphoinositide 3-kinase (PI3K), serine/threonine-specific protein kinase (AKT) and Von Hippel-Lindau (VHL) proteins, which are involved in the regulation of HIF-1 alpha and are highly associated with angiogenesis. Results: A total of 13 HUVECs-specific HLJDD components were identified, and 10 of them were shown to protect against OGD/R injury. We were the first to demonstrate that two of these components have a protective role in OGD/R-induced HUVECs injury. Additionally, seven of these 10 components exhibited angiogenesis-promoting activity, and two of these components were shown, for the first time, to promote angiogenesis in HUVECs. These effects might occur through the HIF-1 alpha/VEGF pathway. Molecular docking results showed that all six active ingredients could stably bind to PI3K and AKT proteins, suggesting that these two proteins may be potential targets for six active ingredients. Conclusions: The approach employed in this study effectively identified proangiogenic components in HLJDD that might act via PI3K/AKT/HIF-1 alpha/VEGF pathways and other mechanisms involved in angiogenesis. In conclusion, this study was the first to demonstrate four compounds with new bioactivities and could also provide insight into

学科与关键词

关键词
Huanglian Jiedu decoctionSolid -phase extractionLive cell biospecific extractionUPLC-Orbitrap fusion tribrid MSAngiogenesisMolecular docking
相关
加载中…
  • Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis
    Li, Xing; Wei, Shizhang; Niu, Shengqi; Ma, Xiao; Li, Haotian; Jing, Manyi; Zhao, Yanling*Computers in Biology and Medicine, 2022, 144: 105389.被引 106
  • Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui; Li, Rong; Chen, Shulin; Wu, Hui; Cai, Yinhe; Li, Junlong; Zhao, Xinjun; Chu, Qingmin; Luo, Chuanjin; Qing, Lijin; Li, Nan*; Wu, Wei*Journal of Healthcare Engineering, 2022, 2022: 2457706.被引 2
  • Cell membrane-coated biomimetic magnetic nanoparticles for the bio-specific extraction of components from Gualou Guizhi decoction exhibiting activities against oxygen-glucose deprivation/reperfusion injury
    He, Dongmei; Wang, Peng; Liao, Fengyun*; Yu, Lingling; Gan, BingJournal of Pharmaceutical and Biomedical Analysis, 2022, 209: 114528.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-03-01
卷期
第 303 卷
页码
115961
DOI
10.1016/j.jep.2022.115961
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81903775]; Macao Science and Technology Development Fund [FDCT 007/2020/ALC, 0006/2020/AKP]; Guangdong Basic and Applied Basic Research Foundation [2021A1515011626]; Shenzhen-Hong Kong-Macau ST Program [SGDX2020110309420200]; President Foundation of the Fifth Affiliated Hospital, Southern Medical University [YZ2020ZX03]; Research Fund of University of Macau [CPG2022-00005-ICMS]

作者

  • L

    Liao, Fengyun (第一作者)

  • H

    He, Dongmei

    5 · southern med univ

查看全部 6 位作者收起作者
  • L

    Liu, Cuiting

    southern med univ

  • V

    Vong, Chi Teng

  • Z

    Zhong, Zhangfeng (通讯)

  • W

    Wang, Yitao (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417